Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

AMRI Global

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. The company provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

AMRI Global
Mostyn Road, Holywell, Flintshire, Wales, CH8 9DN, United Kingdom
+44 (0)1352 717100
Contact AMRI Global
Website

 Latest Content from PMHub 

Removing the Roadblocks to Effective Patient Treatment

White Papers and Resources | November 22, 2013 | Inizio

How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

White Papers and Resources | November 22, 2013 | Inizio

Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

The Difficulties of Living with Depression Don’t End with the Illness Itself

White Papers and Resources | November 22, 2013 | Inizio

This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

Patient Power: Too Much of a Good Thing?

White Papers and Resources | November 22, 2013 | Inizio

Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding

He who dares wins

White Papers and Resources | November 15, 2013 | Lucid Group Communications Limited

The benefits of including medical experts in your brand planning team

Guide to Customer Experience for Pharma

White Papers and Resources | November 5, 2013 | Blue Latitude Health

Find out how to overcome your customer experience challenges

Does your medical education drive change in clinical practice?

White Papers and Resources | October 18, 2013 | Lucid Group Communications Limited

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Advance the way you work with your experts

White Papers and Resources | September 25, 2013 | Lucid Group Communications Limited

Written by Jan Steele PhD, operations director, Lucid

Pharmacovigilance and adverse event reporting: Five keys for establishing worldwide best practice

White Papers and Resources | September 19, 2013 | Merrill Brink International

Pharmacovigilance, an arm of patient care with a charter to make the best use of medicines and data for the treatment or prevention of disease, is taking on growing importance...

Ensuring you are EU Medical Device e-labelling compliant – A best practice strategy

White Papers and Resources | September 19, 2013 | Merrill Brink International

The EU Directive No 207/2012 on electronic labelling for Instructions for Use (IFUs) for certain medical devices was adopted effective March 9, 2012.